Breast Cancer News (@breastcanews) 's Twitter Profile
Breast Cancer News

@breastcanews

ID: 850272360519262210

calendar_today07-04-2017 09:01:42

1,1K Tweet

1,1K Followers

876 Following

Exploration of Targeted Anti-tumor Therapy (@etat_journal) 's Twitter Profile Photo

ARTICLE SHARING! 🔔 Development and validation of an infrared-artificial intelligence software for breast cancer detection #breastcancer, #infrared thermography, #artificialintelligence , #mammography, #screening explorationpub.com/Journals/etat/…

ORBS Conferences (@orbsmeetings) 's Twitter Profile Photo

ORBS 2023 has a whole new look but the same great content. Registration, website and programme to be launched very soon. Keep the 25th-27th September 2023 free! #ORBS2023 #newlookORBS #excitingtimes

ORBS 2023 has a whole new look but the same great content. Registration, website and programme to be launched very soon. Keep the 25th-27th September 2023 free! #ORBS2023 #newlookORBS #excitingtimes
Susie Sun (@susiesunmd) 's Twitter Profile Photo

So proud of our fellow Ashley Woodfin presenting our poster on surgical outcomes in #TNBC following NACT w/ #KEYNOTE522 protocol. 86% axillar pCR and 75% overall pCR rate. Trade off with 24.1% postop complications, 9.2% steroid use at time of surgery. ASBrS MD Anderson Cancer Center #ASBrS23

So proud of our fellow <a href="/aawoodfin/">Ashley Woodfin</a> presenting our poster on surgical outcomes in #TNBC following NACT w/ #KEYNOTE522 protocol. 86% axillar pCR and 75% overall pCR rate. Trade off with 24.1% postop complications, 9.2% steroid use at time of surgery. <a href="/ASBrS/">ASBrS</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #ASBrS23
Dr. Lillian Erdahl MD (@lillianerdahlmd) 's Twitter Profile Photo

“It is time to focus on the harms of NOT screening women 40-49 years old for breast cancer”—Dr. Helen Pass #ASBrS23 #bcsm #bcww #EndTheConfusion

“It is time to focus on the harms of NOT screening women 40-49 years old for breast cancer”—Dr. Helen Pass

#ASBrS23 
#bcsm 
#bcww 
#EndTheConfusion
Akiko Chiba, MD, FACS (@chibaakiko) 's Twitter Profile Photo

Cannot agree more. We need breast cancer risk assessment before age 25. Otherwise we will be missing the opportunity to screen earlier for those at INCREASED risk of breast cancer! #bcsm #breastcancer

Jame Abraham, MD, FACP (@jamecancerdoc) 's Twitter Profile Photo

New US Preventive Task Force #breastcancer screening guideline draft - changed to 40 - 74 years, every other year, major change from the past uspreventiveservicestaskforce.org/uspstf/draft-r… OncoAlert

New US Preventive Task Force #breastcancer screening guideline draft - changed to 40 - 74 years, every other year, major change from the past uspreventiveservicestaskforce.org/uspstf/draft-r… <a href="/OncoAlert/">OncoAlert</a>
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

There's still time to register for Updates on Advanced Breast Cancer: Local Management and Other Perspectives on May 12-13. Register now: fal.cn/3y7Oq #BreastCancer #EndCancer

There's still time to register for Updates on Advanced Breast Cancer: Local Management and Other Perspectives on May 12-13.  

Register now: fal.cn/3y7Oq #BreastCancer #EndCancer
Randy C. Miles MD, MPH, FSBI (@rmilesmd) 's Twitter Profile Photo

Postmenopausal women with #BreastCancer adapt well to #EndocrineTherapy Juan Ignacio Arraras, PhD, et al. U. Hospital of Navarra, Pamplona ow.ly/ln6450OmzSn Healio #Tamoxifen #AromataseInhibitor

Postmenopausal women with #BreastCancer adapt well to #EndocrineTherapy
Juan Ignacio Arraras, PhD, et al. U. Hospital of Navarra, Pamplona
ow.ly/ln6450OmzSn
<a href="/GoHealio/">Healio</a>
#Tamoxifen #AromataseInhibitor
Jame Abraham, MD, FACP (@jamecancerdoc) 's Twitter Profile Photo

Real-World First-Line Use of Pertuzumab With Different Taxanes for Her-2 + Metastatic #breastcancer: A Comparative Effectiveness Study Using US EMR JCO Oncology Practice ASCO OncoAlert ascopubs.org/doi/10.1200/OP… Good old Paclitaxel is still as good as docetaxel or Nab-Paclitaxel !!

Real-World First-Line Use of Pertuzumab With Different Taxanes for Her-2 + Metastatic #breastcancer:  A Comparative Effectiveness Study Using US EMR  <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> <a href="/ASCO/">ASCO</a> <a href="/OncoAlert/">OncoAlert</a>  ascopubs.org/doi/10.1200/OP… Good old Paclitaxel is still as good as docetaxel or Nab-Paclitaxel !!
Endomag, A Hologic Company (@endomag) 's Twitter Profile Photo

Seed Localisation + SLNB in one platform. Backed by data and trusted by surgeons. That's why it's the UK's #1 Tissue localisation platform. #ABSConference2023 #MagTeam #ATNEC

Endomag, A Hologic Company (@endomag) 's Twitter Profile Photo

Are you ready to level up your TAD technique? Learn from two of Europe's best, as Dr Andreas Karakatsanis (he/him) and Mr Peter Barry share their first-hand experience of the unrivalled magnetic approach using both Magseed and Magtrace. Watch below 👇

Stryker Endoscopy (@strykerendo) 's Twitter Profile Photo

It’s official! Stryker’s SPY-PHI System and SPY AGENT GREEN are now the only #FluorescenceImaging system and optical imaging agent on-label for imaging lymph nodes and lymphatic vessels during #LymphaticMapping in adults with breast cancer!

It’s official! Stryker’s SPY-PHI System and SPY AGENT GREEN are now the only #FluorescenceImaging system and optical imaging agent on-label for imaging lymph nodes and lymphatic vessels during #LymphaticMapping in adults with breast cancer!
Randy C. Miles MD, MPH, FSBI (@rmilesmd) 's Twitter Profile Photo

Racial & Ethnic Disparities in Locoregional Recurrence Among Patients w/ Hormone Receptor–Positive, Node-Negative #BreastCancer : A Post Hoc Analysis of TAILORx Randomized Clinical Trial JAMA Surgery⁩ ⁦JAMA Network⁩ jamanetwork.com/journals/jamas…

Northwestern Medicine (@northwesternmed) 's Twitter Profile Photo

Often associated with #BreastCancer, #BRCA1 and #BRCA2 gene mutations put men at higher risk of other types of #cancer, too. Learn about #GeneticTesting. ms.spr.ly/6019gm4O3

Endomag, A Hologic Company (@endomag) 's Twitter Profile Photo

Did you know just switching to Magtrace can save hospitals up to $1,000 per patient, without compromising on quality? See the recent data from Dr. Rhiana Menen MD, which shows the various health economic benefits you could unlock 👇

Endomag, A Hologic Company (@endomag) 's Twitter Profile Photo

By introducing Magtrace, Dr. Rhiana Menen eliminated reliance on nuclear medicine and reduced time from referral through to surgery by 11 days. See why her data shows you can improve the patient experience, treat more patients and make savings for your hospital in the process 👇

By introducing Magtrace, Dr. Rhiana Menen eliminated reliance on nuclear medicine and reduced time from referral through to surgery by 11 days.

See why her data shows you can improve the patient experience, treat more patients and make savings for your hospital in the process 👇